Newswise — NEW YORK, NY, May 3, 2012 – Charity Navigator, America’s premier independent charity evaluator, has awarded the Cancer Research Institute (CRI) its highest charity rating, four out of four stars, placing it among the top organizations out of more than 5,400 U.S. charities and distinguishing CRI as one of the highest-rated cancer charities.
The Cancer Research Institute achieved the coveted 4-star rating by demonstrating efficient use of donor dollars, growing its programmatic capacity, and providing free and easy access to important financial and other key business documents that inform donors about how and where CRI spends their donations as well as how those decisions are made, who makes them, and how they are accounted for.
“We are pleased and proud to once again receive the highest rating from Charity Navigator,” said Jill O’Donnell-Tormey, Ph.D., chief executive officer and director of scientific affairs for the Cancer Research Institute. “Charity ratings help donors make difficult decisions about where to place their trust and money. The top ratings we receive from Charity Navigator and other charity evaluation organizations give our donors confidence that CRI’s priority is to make the most of their generous support and have the greatest possible impact in the fight against cancer.”
According to Ken Berger, president and CEO of Charity Navigator, the 4-star rating indicates that CRI adheres to good governance and other best practices that minimize the chance of unethical activities, and consistently executes its mission in a fiscally responsible way.
The Institute also currently holds an “A” rating from the American Institute of Philanthropy, meets the Better Business Bureau’s Standards for Charitable Accountability and is a BBB Wise Giving Alliance Charity Seal Holder, and has been named a “top 100 charity” by GiveSpot.com.
For more information about the Institute’s charity ratings, go to: http://www.cancerresearch.org/ratings.html.
About the Cancer Research InstituteThe Cancer Research Institute (CRI), established in 1953, is the world’s only nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts to develop new and effective immune system-based strategies to prevent, diagnose, treat, and cure cancer. Guided by a world-renowned Scientific Advisory Council that includes three Nobel laureates and 29 members of the National Academy of Sciences, CRI has invested more than $200 million in support of research conducted by immunologists and tumor immunologists at the world’s leading medical centers and universities, and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment.
To accelerate the pace of progress in the field, CRI convenes and coordinates global collaborations among academics, industry scientists and decision makers, regulatory representatives, and health research associations focused on discovery, development, and refinement of new cancer immunotherapies. A founding visionary and scientific leader in tumor immunology, CRI is helping to shape the emerging field of immuno-oncology, and is ushering in a new era of medical progress to bring more treatment options to cancer patients sooner.
# # #
RSS